Comparative study of subcutaneous, intramuscular, and intravenous administration of human insulin
- PMID: 6113483
- DOI: 10.1016/s0140-6736(81)90300-7
Comparative study of subcutaneous, intramuscular, and intravenous administration of human insulin
Abstract
Human insulin derived from porcine insulin was given subcutaneously (s.c.), intramuscularly (i.m.), and intravenously (i.v.) to normal men. The dosage for all three routes was 0 . 075 IU/kg body weight. Diluting medium was administered by s.c. injection to obtain control values. Somatostatin (100 microgram/h) was given to inhibit pancreatic beta cell secretion. The plasma glucose responses to s.c. injection of this insulin into the anterior abdominal wall and to i.m. injection into the thigh were similar with respect to the extent, onset, and duration of effect. Plasma glucose fell from mean (+/- SE) pre-injection values of 4 . 3 +/- 0 . 15 and 4 . 4 +/- 0 . 27 mmol/l, to 3 . 06 +/- 0 . 25 and 2 . 98 +/- 0 . 16 mmol/l by 90 to 105 min for s.c. and i.m. studies, respectively, thereafter returning to mean basal level by 6 h after i.m. injection, but remaining about 0 . 5 mmol/l below basal level after s.c. injection. A much more sudden, but short-lived, hypoglycaemic response occurred after i.v. insulin, with plasma glucose failing from 4. 50 +/- 0 . 42 to 1 . 45 +/- 0 . 16 mmol/l by 25 min, returning to mean basal value after 3 1/2 h. The mean (+/- SE) peak insulin levels after s.c. and i.m. injection were 0 . 13 +/- 0 . 01 and 0 . 18 +/- 0 . 04 pmol/ml at 90 and 60 min, respectively. After i.v. injection the maximum plasma insulin concentration of 6 . 9 +/- 0 . 73 pmol/ml was seen at 2 min. No adverse side-effects were observed.
Similar articles
-
Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.Diabetes Care. 1995 Nov;18(11):1452-9. doi: 10.2337/diacare.18.11.1452. Diabetes Care. 1995. PMID: 8722069
-
A study of the comparative safety and efficacy of neutral soluble human (semi-synthetic) and porcine monocomponent insulin in non-diabetic subjects.Diabete Metab. 1982 Jun;8(2):155-8. Diabete Metab. 1982. PMID: 7049781 Clinical Trial.
-
The clinical pharmacology of human insulin (Novo) in normal subjects.Diabetes Care. 1983 Mar-Apr;6 Suppl 1:13-6. Diabetes Care. 1983. PMID: 6133710
-
Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.Diabetes Care. 2000 Jun;23(6):807-12. doi: 10.2337/diacare.23.6.807. Diabetes Care. 2000. PMID: 10841001
-
Different absorption of isophane (NPH) insulin from subcutaneous and intramuscular sites suggests a need to reassess recommended insulin injection technique.Diabet Med. 1990 Aug;7(7):600-2. doi: 10.1111/j.1464-5491.1990.tb01456.x. Diabet Med. 1990. PMID: 2146067 Clinical Trial.
Cited by
-
Low subcutaneous degradation and slow absorption of insulin in insulin-dependent diabetic patients during continuous subcutaneous insulin infusion at basal rate.Diabetologia. 1984 Aug;27(2):238-41. doi: 10.1007/BF00273813. Diabetologia. 1984. PMID: 6386586
-
Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy.Clin Pharmacokinet. 1985 Jul-Aug;10(4):303-14. doi: 10.2165/00003088-198510040-00002. Clin Pharmacokinet. 1985. PMID: 3899451 Review.
-
Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use.Drugs. 1987 Sep;34(3):350-71. doi: 10.2165/00003495-198734030-00003. Drugs. 1987. PMID: 3315622 Review.
-
Drug delivery interfaces in the 21st century: from science fiction ideas to viable technologies.Mol Pharm. 2013 Oct 7;10(10):3531-43. doi: 10.1021/mp4003283. Epub 2013 Aug 26. Mol Pharm. 2013. PMID: 23915375 Free PMC article.
-
Impact of injection sites for soluble insulin on glycaemic control in type 1 (insulin-dependent) diabetic patients treated with a multiple insulin injection regimen.Diabetologia. 1993 Aug;36(8):752-8. doi: 10.1007/BF00401147. Diabetologia. 1993. PMID: 8405743 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical